Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

INO 5151

Next Previous
Search
Drug Profile

INO 5151

Alternative Names: INO-5151; INO-9012/INO-5150

Latest Information Update: 22 Nov 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Inovio Pharmaceuticals
  • Developer Inovio Pharmaceuticals; Parker Institute for Cancer Immunotherapy
  • Class Cancer vaccines; DNA vaccines; Immunotherapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Prostate cancer

Most Recent Events

  • 03 Oct 2022 Parker Institute for Cancer Immunotherapy completes its phase I PORTER trial in Prostate cancer (Metastatic disease, Second-line therapy or greater, Hormone refractory, Combination therapy) in USA (IM) NCT03835533)
  • 31 Dec 2020 Phase-II clinical trials in Prostate cancer (Combination therapy, Hormone refractory, Metastatic disease, Second-line therapy or greater) in USA (IM) prior to December 2020 (Inovio Pharmaceuticals pipeline, April 2021)
  • 12 Aug 2019 Inovio Pharmaceuticals and Parker Institute for Cancer Immunotherapy extend the clinical collaboration to evaluate INO 5151 in Prostate cancer

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top